drugset / Trial / NCT02324270

Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain

NCT02324270

Phase 3 Completed 658 enrolled Actavis Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To demonstrate the therapeutic efficacy of a generic diclofenac epolamine patch against Flector patch in the treatment of pain in subjects with minor ankle sprain

Timeline

Start
2014-05
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac epolamine Unknown 1.3 % Topical

Indications

No indication recorded.